Cutaneous follicle center lymphoma, intra-abdominal lymph nodes
ICD-10 C82.63 is a billable code used to indicate a diagnosis of cutaneous follicle center lymphoma, intra-abdominal lymph nodes.
Cutaneous follicle center lymphoma (CFCL) is a subtype of non-Hodgkin lymphoma that primarily affects the skin and is characterized by the proliferation of follicle center (germinal center) B-cells. When CFCL involves intra-abdominal lymph nodes, it indicates a more advanced stage of the disease, often associated with systemic symptoms. Patients may present with localized skin lesions, which can be mistaken for other dermatological conditions. The disease can progress to involve lymph nodes, particularly in the abdomen, leading to complications such as lymphadenopathy and potential organ involvement. Staging of CFCL is crucial, as it helps determine the extent of the disease and guides treatment options. B-symptoms, including fever, night sweats, and weight loss, may be present and indicate a more aggressive disease course. Treatment protocols typically involve a combination of chemotherapy, immunotherapy, and possibly radiation therapy, tailored to the individual patient's disease stage and overall health status.
Detailed clinical notes on staging, treatment plans, and patient responses.
Patients presenting with skin lesions and abdominal lymphadenopathy.
Ensure comprehensive documentation of B-symptoms and treatment responses.
Thorough descriptions of skin lesions and any associated systemic symptoms.
Diagnosis of skin lesions that may be indicative of underlying lymphoma.
Collaboration with oncology for accurate staging and treatment documentation.
Used for patients receiving chemotherapy for CFCL.
Document the specific chemotherapy regimen and patient response.
Oncology specialists must ensure accurate coding of chemotherapy administration.
Common symptoms include skin lesions, lymphadenopathy, and systemic B-symptoms such as fever, night sweats, and weight loss.
